Literature DB >> 25076794

Use of an Additional Diagnostic Work-up Following a Treatment Recommendation from the Preoperative Conference of the Mammography Screening Units.

K-J Winzer1, S Unger1, U Bick2, F Dieckmann3, E Fallenberg4.   

Abstract

Objective: If a focus of suspicion is classified as being B 3-5 by a punch biopsy as part of a mammography screening, a recommendation for further action to be taken will be given in the preoperative conference of the screening unit. As part of this investigation, these treatment recommendations were compared with the final therapeutic approach taken at a certified breast centre. Furthermore, it was investigated whether and which additional examinations were performed on patients, depending on compliance with the recommended treatment. Material and Method: The data from 272 breast cancer patients from the years 2007, 2008 and 2009 was analysed. The patients took part in the screening programmes of four screening units in the German mammography screening programme, in one federal state. In addition, the data from each patient from one screening unit was analysed in two further federal states.
Results: In total, the most recently conducted intervention deviated from the treatment recommendation from the preoperative conference in the screening unit in 77 out of 272 patients (28.3 %). Of these, there were 50 recommendations for open biopsy which ultimately resulted in breast-conserving surgery, which is not to be evaluated as an error, as the bioptic result was supplemented by the open biopsy. Additional examinations were performed in patients with deviating treatment recommendation in 39 cases (50.6 %) and in patients without deviating treatment recommendation in 66 cases (34.0 %). The additional examinations carried out included additional punch biopsies (most frequent) and MRI scans, but also additional ultrasounds or a mammography. Conclusions: Additional examinations lead to a change in treatment in a higher percentage of patients in comparison with the initial screening including assessment. An exact reexamination of the findings obtained in the screening is therefore preoperatively necessary in order to guarantee optimum treatment.

Entities:  

Keywords:  mammary carcinoma; mammography screening; ultrasound

Year:  2014        PMID: 25076794      PMCID: PMC4078142          DOI: 10.1055/s-0033-1360322

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  13 in total

1.  Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease.

Authors:  B Won; H E Reynolds; C L Lazaridis; V P Jackson
Journal:  AJR Am J Roentgenol       Date:  1999-07       Impact factor: 3.959

2.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.

Authors:  R J Jackman; F Burbank; S H Parker; W P Evans; M C Lechner; T R Richardson; A A Smid; H B Borofsky; C H Lee; H M Goldstein; K J Schilling; A B Wray; R F Brem; T H Helbich; D E Lehrer; S J Adler
Journal:  Radiology       Date:  2001-02       Impact factor: 11.105

3.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.

Authors:  Wendie A Berg; Zheng Zhang; Daniel Lehrer; Roberta A Jong; Etta D Pisano; Richard G Barr; Marcela Böhm-Vélez; Mary C Mahoney; W Phil Evans; Linda H Larsen; Marilyn J Morton; Ellen B Mendelson; Dione M Farria; Jean B Cormack; Helga S Marques; Amanda Adams; Nolin M Yeh; Glenna Gabrielli
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Intraoperative specimen radiography in patients with nonpalpable malignant breast lesions.

Authors:  C Schmachtenberg; F Engelken; T Fischer; U Bick; A Poellinger; E M Fallenberg
Journal:  Rofo       Date:  2012-05-22

6.  Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Authors:  Peter A Fasching; Katharina Heusinger; Christian R Loehberg; Evelyn Wenkel; Michael P Lux; Michael Schrauder; Thomas Koscheck; Werner Bautz; Rüdiger Schulz-Wendtland; Matthias W Beckmann; Mayada R Bani
Journal:  Eur J Radiol       Date:  2006-10-09       Impact factor: 3.528

7.  Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy.

Authors:  S Weigel; T Decker; E Korsching; C Biesheuvel; A Wöstmann; W Böcker; D Hungermann; K Roterberg; J Tio; W Heindel
Journal:  Rofo       Date:  2011-04-19

8.  The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast.

Authors:  R M Mann; J Veltman; J O Barentsz; T Wobbes; J G Blickman; C Boetes
Journal:  Eur J Surg Oncol       Date:  2007-06-15       Impact factor: 4.424

9.  Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.

Authors:  Wendie A Berg; Jeffrey D Blume; Jean B Cormack; Ellen B Mendelson; Daniel Lehrer; Marcela Böhm-Vélez; Etta D Pisano; Roberta A Jong; W Phil Evans; Marilyn J Morton; Mary C Mahoney; Linda Hovanessian Larsen; Richard G Barr; Dione M Farria; Helga S Marques; Karan Boparai
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

10.  Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study.

Authors:  Ute Kettritz; Kerstin Rotter; Ingrid Schreer; Margarete Murauer; Rüdiger Schulz-Wendtland; Daniela Peter; Sylvia H Heywang-Köbrunner
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.